Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHAWN B BACA

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1649373523
CMS profile
865327
Location
DELRAY BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$4,608.88

152 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,382.06 145
Travel and Lodging $1,131.83 6
Education $94.99 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHAWN B BACA

NPI 1649373523 · CMS profile ID 865327

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

DELRAY BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649373523?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHAWN B BACA, NPI 1649373523, CMS profile ID 865327. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649373523?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SHAWN B BACA, NPI 1649373523, CMS profile ID 865327. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649373523?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SHAWN B BACA, NPI 1649373523, CMS profile ID 865327, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1649373523?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

152 matching records · $4,608.88 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 152 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 152.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Radius Health, Inc. $31.3603/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249523284 CMS
Alvogen Inc $31.5703/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1209951732 CMS
Novartis Pharmaceuticals Corporation $26.4603/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200013143 CMS
ABBVIE INC. $34.5403/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452515 CMS
UCB, Inc. $43.3303/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224354317 CMS
Genentech USA, Inc. $19.7303/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211588880 CMS
GlaxoSmithKline, LLC. $17.9503/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190744865 CMS
UCB, Inc. $24.9303/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224354315 CMS
ABBVIE INC. $16.4203/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452513 CMS
Aurinia Pharma U.S., Inc. $24.1303/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249411929 CMS
Amgen Inc. $20.3002/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228351242 CMS
E.R. Squibb & Sons, L.L.C. $19.9702/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184827519 CMS
E.R. Squibb & Sons, L.L.C. $1.4402/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184827523 CMS
Novartis Pharmaceuticals Corporation $23.1702/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200013141 CMS
PFIZER INC. $17.1902/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231363476 CMS
GENZYME CORPORATION $27.6102/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233261834 CMS
Novartis Pharmaceuticals Corporation $17.1502/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200013137 CMS
UCB, Inc. $37.1402/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224354313 CMS
Janssen Biotech, Inc. $24.9102/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175076004 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.9902/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223942299 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.9902/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223942301 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.0002/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223942937 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.2202/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223943015 CMS
Takeda Pharmaceuticals U.S.A., Inc. $64.3302/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224099264 CMS
Takeda Pharmaceuticals U.S.A., Inc. $78.2002/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224099308 CMS
Takeda Pharmaceuticals U.S.A., Inc. $428.1802/08/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224100050 CMS
ABBVIE INC. $24.4002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452511 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.9902/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223942297 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.0002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223942935 CMS
Takeda Pharmaceuticals U.S.A., Inc. $74.9902/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223943161 CMS
Takeda Pharmaceuticals U.S.A., Inc. $209.9602/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224099666 CMS
Takeda Pharmaceuticals U.S.A., Inc. $74.9902/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223943159 CMS
Takeda Pharmaceuticals U.S.A., Inc. $124.9902/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223943408 CMS
Takeda Pharmaceuticals U.S.A., Inc. $141.2002/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224099518 CMS
Takeda Pharmaceuticals U.S.A., Inc. $209.9602/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224099664 CMS
Amgen Inc. $18.1402/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228351244 CMS
ABBVIE INC. $25.9902/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452509 CMS
Amgen Inc. $24.7102/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228351240 CMS
Novartis Pharmaceuticals Corporation $22.9101/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200013139 CMS
ABBVIE INC. $19.2001/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452507 CMS
PFIZER INC. $19.6601/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231206625 CMS
ABBVIE INC. $26.2701/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201452505 CMS
GlaxoSmithKline, LLC. $25.1401/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190379743 CMS
Novartis Pharmaceuticals Corporation $17.6601/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200013135 CMS
Lilly USA, LLC $20.5501/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186940929 CMS
Amgen Inc. $8.8901/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227182623 CMS
E.R. Squibb & Sons, L.L.C. $29.6601/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184827499 CMS
E.R. Squibb & Sons, L.L.C. $0.6201/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184827501 CMS
Alexion Pharmaceuticals, Inc. $26.2101/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202914442 CMS
Janssen Biotech, Inc. $20.7001/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175072165 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,255.88 198
PY2020 $681.98 39
PY2021 $1,757.23 120
PY2022 $2,746.04 170
PY2023 $4,228.06 191
PY2024 $2,969.75 139
PY2025 $4,608.88 152

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $609,148.24 11
PY2024 Principal investigator $585,331.59 7
PY2023 Principal investigator $99,972.37 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $20.00 12/01/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
A Randomized, Parallel Group, Double Blind, Placebo Controlled Multicenter Phase III Trial to Investigate the Efficacy and Safety of Secukinumab 300 mg Administered Subcutaneously Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patien No dispute reported 06/30/2026 1190300737
Principal investigator 1 Novartis Pharmaceuticals Corporation $17.12 11/15/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Pol No dispute reported 06/30/2026 1190300731
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,060.00 05/20/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH INC
A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001) No dispute reported 06/30/2026 1223279964
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,111.00 04/23/2025 Non-covered Recipient Entity
LONG ISLAND REGIONAL ARTHRITIS AND OSTEOPOROSIS CARE, PC
A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Polymyositis No dispute reported 06/30/2026 1185538911
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,616.40 03/28/2025 Non-covered Recipient Entity
RHEUMATOLOGY ASSOCIATES OF SOUTH FLORIDA
A Multicenter,Randomized,Double blind,Placebo controlled,Phase III Study to Evaluate the Efficacy and Safety of Anifrolumab in Adult Patients with Systemic Sclerosis No dispute reported 06/30/2026 1185538915
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8,000.00 02/25/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH INC
A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001) No dispute reported 06/30/2026 1223275539
Principal investigator 1 Novartis Pharmaceuticals Corporation $280,304.35 02/10/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR) No dispute reported 06/30/2026 1190300735
Principal investigator 1 AstraZeneca Pharmaceuticals LP $24,192.21 01/31/2025 Non-covered Recipient Entity
RHEUMATOLOGY ASSOCIATES OF SOUTH FLORIDA
A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Polymyositis No dispute reported 06/30/2026 1185538913
Principal investigator 1 Novartis Pharmaceuticals Corporation $231,433.76 01/13/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment No dispute reported 06/30/2026 1190300729
Principal investigator 1 Novartis Pharmaceuticals Corporation $49,163.40 01/10/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Pol No dispute reported 06/30/2026 1190300733
Principal investigator 1 Novartis Pharmaceuticals Corporation $230.00 01/01/2025 Non-covered Recipient Entity
RASF CLINICAL RESEARCH CENTER
A Randomized, Parallel Group, Double Blind, Placebo Controlled Multicenter Phase III Trial to Investigate the Efficacy and Safety of Secukinumab 300 mg Administered Subcutaneously Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patien No dispute reported 06/30/2026 1190300739